EU Launches Joint Scientific Consultations to E...

By João L. Carapinha

January 14, 2026

Launching Joint Scientific Consultations in 2026 The European Commission has initiated the first submission period for Joint Scientific Consultations under the EU Health Technology As...
Empowering Leaders at the Global Pharma Executive Course: Navigating Industry...
Johnson & Johnson’s Medicine Access Agreement: Paving the Way for ...
Childhood Immunization Reforms: Aligning U.S. Schedules with Global Standards
INFARMED Leadership Appointments: A New Era in Health Regulation and Expertise
Transforming EU Pharmaceutical Legislation: EMA’s Strategic Priorities ...
AKEEGA BRCA2 Approval: Landmark FDA Decision for Precision Therapy in Aggress...
Translational Medicine Portugal: Driving Collaborative Innovations in Healthcare
Shifting Toward Sustainable Reimbursement Models in South Africa’s Heal...
Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 202...
Barriers to African Pharmaceutical Growth: Navigating Regulatory and Procurem...
Challenging the Narrative: Pharmaceutical Innovation Funding and Its Complex ...
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...